Surprisingly, non-clonal cells from CLL patients with the polymorphism showed levels of HSP90B1 mRNA similar to that of wild-type CLL patients (both CD19+ and non-CD19+ fraction cells). This evidence concerns the gene HSP90B1 and B-cell chronic lymphocytic leukemia.